As in case of Celastrol, Plumbagin inhibited the proliferation of patient-derived AML to a stronger extent than the proliferation of normal hematopoietic progenitors, which is in line with the MYB addiction of the leukemia cells. The gene discussed is MYB; the disease is acute myeloid leukemia.